Company Filing History:
Years Active: 2018
Title: Idit Amar-Yuli: Innovator in Liquid Crystal Technology
Introduction
Idit Amar-Yuli is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of liquid crystal technology, particularly in the development of systems that enhance the delivery of bio-macromolecules and active materials. Her innovative work has implications for both therapeutic and non-therapeutic applications.
Latest Patents
Idit Amar-Yuli holds 1 patent related to reverse hexagonal mesophase (H) liquid crystals. This patent provides multi-component hexagonal systems designed for solubilizing and protecting bio-macromolecules and active materials from degradation. The invention is particularly relevant for oral delivery systems, where the mesophase is adapted for oral administration. The formation of mesophase systems involves ternary glycerol monooleate (GMO)/water combinations that include at least one triglyceride or an equivalent. Additionally, the system incorporates at least one biomacromolecule or drug within the mesophase of a pharmaceutical composition or oral delivery system.
Career Highlights
Idit Amar-Yuli is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her work at this esteemed institution has allowed her to explore and develop innovative solutions in the field of liquid crystals.
Collaborations
Idit has collaborated with notable colleagues, including Nissim Garti and Abraham Aserin, who have contributed to her research endeavors.
Conclusion
Idit Amar-Yuli's contributions to liquid crystal technology exemplify her innovative spirit and dedication to advancing the field. Her patent on reverse hexagonal mesophase systems highlights her role as a leading inventor in the area of bio-macromolecule delivery.